CN1401343A - 一种治疗颈椎病的中药复方制剂及制备方法 - Google Patents
一种治疗颈椎病的中药复方制剂及制备方法 Download PDFInfo
- Publication number
- CN1401343A CN1401343A CN01126559A CN01126559A CN1401343A CN 1401343 A CN1401343 A CN 1401343A CN 01126559 A CN01126559 A CN 01126559A CN 01126559 A CN01126559 A CN 01126559A CN 1401343 A CN1401343 A CN 1401343A
- Authority
- CN
- China
- Prior art keywords
- preparation
- cervical spondylosis
- artificial
- chinese medicinal
- moschus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims description 54
- 206010041591 Spinal osteoarthritis Diseases 0.000 title claims description 32
- 208000036319 cervical spondylosis Diseases 0.000 title claims description 32
- 208000005801 spondylosis Diseases 0.000 title claims description 32
- 150000001875 compounds Chemical class 0.000 title claims description 16
- 238000000034 method Methods 0.000 title claims description 12
- 230000008569 process Effects 0.000 title description 2
- 239000002775 capsule Substances 0.000 claims abstract description 12
- 239000006187 pill Substances 0.000 claims abstract description 9
- 239000003826 tablet Substances 0.000 claims abstract description 4
- 241000972155 Moschus Species 0.000 claims description 51
- 229940079593 drug Drugs 0.000 claims description 37
- 239000009636 Huang Qi Substances 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000011265 semifinished product Substances 0.000 claims description 8
- 229940040145 liniment Drugs 0.000 claims description 7
- 239000000865 liniment Substances 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 230000003203 everyday effect Effects 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 229940124531 pharmaceutical excipient Drugs 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000005325 percolation Methods 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 238000009702 powder compression Methods 0.000 claims description 2
- 238000011287 therapeutic dose Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 239000002245 particle Substances 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 abstract 1
- 206010004542 Bezoar Diseases 0.000 abstract 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 201000005671 spondyloarthropathy Diseases 0.000 abstract 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 27
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 27
- 235000021286 stilbenes Nutrition 0.000 description 27
- 239000008280 blood Substances 0.000 description 25
- 210000004369 blood Anatomy 0.000 description 25
- 230000036541 health Effects 0.000 description 22
- 208000002193 Pain Diseases 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 10
- 230000000202 analgesic effect Effects 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 206010061246 Intervertebral disc degeneration Diseases 0.000 description 5
- 206010028836 Neck pain Diseases 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010017577 Gait disturbance Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000003387 muscular Effects 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 210000000278 spinal cord Anatomy 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 206010020565 Hyperaemia Diseases 0.000 description 3
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical group CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- 208000018180 degenerative disc disease Diseases 0.000 description 3
- 230000001934 delay Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 229960001680 ibuprofen Drugs 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 208000021600 intervertebral disc degenerative disease Diseases 0.000 description 3
- 231100001252 long-term toxicity Toxicity 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 101710145505 Fiber protein Proteins 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028570 Myelopathy Diseases 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000003461 brachial plexus Anatomy 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000011552 rat model Methods 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 102000004091 Caspase-8 Human genes 0.000 description 1
- 108090000538 Caspase-8 Proteins 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 206010037779 Radiculopathy Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 206010040026 Sensory disturbance Diseases 0.000 description 1
- 208000007613 Shoulder Pain Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000021945 Tendon injury Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011265590A CN1177600C (zh) | 2001-08-28 | 2001-08-28 | 一种治疗颈椎病的中药复方制剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011265590A CN1177600C (zh) | 2001-08-28 | 2001-08-28 | 一种治疗颈椎病的中药复方制剂及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1401343A true CN1401343A (zh) | 2003-03-12 |
CN1177600C CN1177600C (zh) | 2004-12-01 |
Family
ID=4666573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011265590A Expired - Lifetime CN1177600C (zh) | 2001-08-28 | 2001-08-28 | 一种治疗颈椎病的中药复方制剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1177600C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198172A (zh) * | 2011-05-26 | 2011-09-28 | 哈尔滨怡康药业有限公司 | 一种治疗风湿痹阻症外敷散剂及其制备方法 |
WO2014201637A1 (zh) * | 2013-06-19 | 2014-12-24 | 上海中医药大学附属龙华医院 | 一种治疗神经根型颈椎病的复方制剂及其制备方法 |
CN112451592A (zh) * | 2020-11-30 | 2021-03-09 | 北京航天情报与信息研究所 | 一种改善腰椎病的中药配方及制备方法 |
CN112451577A (zh) * | 2020-11-30 | 2021-03-09 | 北京航天情报与信息研究所 | 一种改善颈椎病的中药配方及制备方法 |
-
2001
- 2001-08-28 CN CNB011265590A patent/CN1177600C/zh not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198172A (zh) * | 2011-05-26 | 2011-09-28 | 哈尔滨怡康药业有限公司 | 一种治疗风湿痹阻症外敷散剂及其制备方法 |
CN102198172B (zh) * | 2011-05-26 | 2012-11-07 | 哈尔滨怡康药业有限公司 | 一种治疗风湿痹阻症外敷散剂及其制备方法 |
WO2014201637A1 (zh) * | 2013-06-19 | 2014-12-24 | 上海中医药大学附属龙华医院 | 一种治疗神经根型颈椎病的复方制剂及其制备方法 |
CN112451592A (zh) * | 2020-11-30 | 2021-03-09 | 北京航天情报与信息研究所 | 一种改善腰椎病的中药配方及制备方法 |
CN112451577A (zh) * | 2020-11-30 | 2021-03-09 | 北京航天情报与信息研究所 | 一种改善颈椎病的中药配方及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1177600C (zh) | 2004-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101062194A (zh) | 治疗骨病、骨折的药物及制备方法 | |
CN101028376A (zh) | 一种治疗习惯性流产的中药制剂 | |
CN1177600C (zh) | 一种治疗颈椎病的中药复方制剂及制备方法 | |
CN1117582C (zh) | 治疗类风湿关节炎的药物及其制备方法 | |
CN1709314A (zh) | 治疗风湿痛风病的药酒及制备方法 | |
CN1824103A (zh) | 一种治疗跌打损伤和接骨的外用药 | |
CN100496542C (zh) | 一种治疗痹证型颈椎病的中药复方制剂及制备方法 | |
CN100402065C (zh) | 一种治疗痛风的胶囊及其制备工艺 | |
CN1259970C (zh) | 治疗外感风寒的药物及其制备方法 | |
CN1903354A (zh) | 一种治疗腰腿疼的中药 | |
CN1270744C (zh) | 用于治疗腰椎间盘突出症的骨康健生丸 | |
CN102846699B (zh) | 一种治疗缺血性中风的中药组合物及其制备工艺 | |
CN100444882C (zh) | 一种消肿止痛的胶囊及其制备方法 | |
CN1174768C (zh) | 用于治疗骨质增生、颈椎病、椎间盘突出症的外用中药贴 | |
CN1074928C (zh) | 治疗偏瘫的药物及制备方法 | |
CN101361882B (zh) | 治疗风湿骨病的中药制剂 | |
CN101569708B (zh) | 一种治疗缺血性心脏病的药物及其制备方法 | |
CN101028421A (zh) | 一种治疗慢性肾衰的中成药 | |
CN1076622C (zh) | 一种治疗肾炎的中药 | |
CN1745802A (zh) | 一种治疗疼痛的贴膏及其制备方法 | |
CN1404850A (zh) | 消炎止痛退肿外用药 | |
CN1069541C (zh) | 一种治疗癌症的药物 | |
CN1315200A (zh) | 一种治疗腰椎间盘突出症的外用药 | |
CN104857458B (zh) | 一种降血糖的中药组合制剂及其制备方法 | |
CN100335112C (zh) | 治疗肾虚寒湿性腰痛的中药及其胶囊剂的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI HYUNDAI CHINASE MEDICAL TECHNOLOGY DEVEL Free format text: FORMER OWNER: SHANGHAI UNIV. OF TRADITIONAL CHINESE MEDICINE Effective date: 20030506 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20030506 Address after: 200051 days in Shanghai City Road No. 600 building 7F. Applicant after: Shanghai Sundise Address before: 200032 No. 530, Lingling Road, Shanghai Applicant before: Shanghai University of Traditional Chinese Medicine |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: SHANGHAI HUANGHAI PHARMACEUTICAL Co.,Ltd. Assignor: Shanghai Sundise Contract record no.: 2010990000482 Denomination of invention: Chinese medicine compound preparation for treating cervical spondylosis, and preparing process thereof Granted publication date: 20041201 License type: Exclusive License Open date: 20030312 Record date: 20100701 |
|
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI HUANGHAI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANGHAI MODERN TCM CO., LTD. Effective date: 20130425 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: SHANGHAI MODERN TCM CO., LTD. Free format text: FORMER NAME: SHANGHAI MODERN CHINESE TRADITIONAL MEDICINE TECHNOLOGY DEVELOPMENT CO., LTD. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200050 CHANGNING, SHANGHAI TO: 200942 BAOSHAN, SHANGHAI |
|
CP03 | Change of name, title or address |
Address after: 200050 Shanghai City Zhaofeng Plaza No. 1027 Changning District Changning Road, 33 floor Patentee after: Shanghai Sundise Chinese Medicine Technology Development Co.,Ltd. Address before: 200051 days in Shanghai City Road No. 600 building 7F. Patentee before: Shanghai Sundise |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130425 Address after: 200942 Shanghai City, Baoshan District Sheng Qiao Zhen Shi Tai Road No. 1288 Patentee after: SHANGHAI HUANGHAI PHARMACEUTICAL Co.,Ltd. Address before: 200050 Shanghai City Zhaofeng Plaza No. 1027 Changning District Changning Road, 33 floor Patentee before: Shanghai Sundise Chinese Medicine Technology Development Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20041201 |
|
CX01 | Expiry of patent term |